摘要
目的研究分析支气管哮喘患者接受沙美特罗替卡松辅助治疗的效果。方法根据2014年6月-2015年6月我院的82例支气管哮喘患者来进行研究分析,将这些患者分成对照组和观察组。对照组使用布地奈德治疗,观察组除此外增加沙美特罗替卡松治疗。对两组的患者治疗情况进行比较分析。结果观察组患者的支气管哮喘症状临床消失时间比对照组短,观察组的临床治疗有效率是81%,对照组的治疗有效率是57.5%,两组结果存在统计学差异性（P〈0.05）。结论支气管哮喘患者可以选择沙美特罗替卡松辅助治疗,临床中能够提升患者的肺功能指标,且没有不良反应情况存在,安全性较高。
Objective To study the effect of salmeterol therapy in patients with bronchial asthma. Methods 82 cases of bronchial asthma in our hospital from June 2014 to June 2015 were analyzed. The patients were divided into control group and observation group. The control group treated with budesonide, the observation group in addition to increase the treatment of salmeterol. The treatment of two groups of patients were compared and analyzed. Results The effective rate of observation group of patients withbronchial asthma clinical symptoms disappeared time than in the control group, the observation group of clinical treatment was 81% and the effective rate of the treatment in the control group was 57.5%. The results of the two groups exist significant difference（P〈0.05）. Conclusion Bronchial asthma patients can choose salmeterol / fluticasone therapy, clinical can improve the index of pulmonary function in patients, and no adverse reaction, high security.
出处
《中国继续医学教育》
2016年第16期148-149,共2页
China Continuing Medical Education
